Medico Remedies Ltd. (MEDICO) Share Price Rises 8.49% Today
- July 29, 2026
- Posted by: Harsh Piplani
- Category: News
Medico Remedies Ltd. Share Price rises 8.49% to Rs 46.63, marking a significant gain in the micro-cap category.
Medico Remedies Ltd. Share Price has experienced a notable increase today, rising by 8.49% to reach Rs 46.63. This significant price rise places the company in the spotlight within the micro-cap category, which requires a minimum day-gain threshold of 5% to qualify as a top gainer. With a market capitalisation of Rs 356.67 crore, Medico Remedies Ltd. has captured investor attention, although the data does not specify a company-specific catalyst for this movement. The Pharmaceuticals & Drugs sector, where the company operates, often sees fluctuations due to various market dynamics, and today’s rally is a testament to the volatile nature of this industry.
Medico Remedies Ltd. (MEDICO) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 46.63 |
| Previous Close | Rs 42.98 |
| Today's Change | +Rs 3.65 (+8.49%) |
| Day Open | Rs 45 |
| Day High | Rs 46.66 |
| Day Low | Rs 42.81 |
| Current Volume (BSE) | 16,263 |
| BSE Traded Volume | 16,263 |
| NSE Traded Volume | 3,41,150 |
| Combined NSE + BSE Volume | 3,57,413 |
| Turnover | Rs 0.08 crore |
| Market Capitalisation | Rs 356.67 crore |
| Market Cap Category | Micro Cap |
Medico Remedies Ltd. (MEDICO) traded at Rs 46.63. versus the previous close of Rs 42.98, a rise of 8.49%. The stock opened at Rs 45, reached Rs 46.66, touched Rs 42.81. Reported volume was 16,263.
Medico Remedies Ltd. (MEDICO) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 356.67 crore |
| P/E Ratio | 27.19x |
| P/B Ratio | 4.73x |
| ROE | 8.31% |
| ROCE | 10.13% |
| EPS | Rs 1.58 |
| Dividend Yield | 0% |
Medico Remedies Ltd. was valued at a P/E ratio of 27.19x, a P/B ratio of 4.73x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of 8.31% and ROCE of 10.13%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Per-share and shareholder-return metrics included EPS of Rs 1.58, dividend yield of 0%. Dividend yield is a current or historical ratio and does not guarantee future distributions.
Medico Remedies Ltd. operates within the Pharmaceuticals & Drugs industry, with a market capitalisation of Rs 356.67 crore. The company’s P/E ratio stands at 27.19, slightly above the industry median of 26.37, indicating a relatively higher valuation compared to some peers. The P/B ratio is 4.73, significantly above the industry median of 1.82, suggesting a premium valuation on book value. The company’s ROE is 8.31%, slightly below the industry median of 10.31%, while the ROCE is 10.13%, also below the industry median of 12.96%. The EPS is Rs 1.58, and the company does not currently offer a dividend yield. These fundamentals provide a mixed picture, with valuation metrics indicating a premium, while profitability ratios suggest room for improvement. Investors may find these insights useful when considering the company’s potential in the context of its industry.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 27.19x |
| Benchmark Median P/E | 26.37x |
| Benchmark Average P/E | 80.74x |
| Benchmark P/E Range | 3.61x to 3,439.3x |
| Company P/B Ratio | 4.73x |
| Benchmark Median P/B | 1.82x |
| Company ROE | 8.31% |
| Benchmark Median ROE | 10.31% |
| Company ROCE | 10.13% |
| Benchmark Median ROCE | 12.96% |
| Company Market Capitalisation | Rs 356.67 crore |
| Benchmark Median Market Cap | Rs 147.71 crore |
Medico Remedies Ltd. (MEDICO) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Medico Remedies Ltd. (MEDICO) has a P/E ratio of 27.19x, which is above the benchmark median of 26.37x, a difference of +3.11%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Medico Remedies Ltd. (MEDICO) has a ROE of 8.31%, which is below the benchmark median of 10.31%, a difference of -19.4%. Medico Remedies Ltd. (MEDICO) has a ROCE of 10.13%, which is below the benchmark median of 12.96%, a difference of -21.84%.
Track today’s top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.
The Pharmaceuticals & Drugs industry, part of the broader Healthcare sector, includes 137 companies. Medico Remedies Ltd.’s P/E ratio of 27.19 is slightly above the industry median of 26.37, suggesting it is valued higher than many of its peers. The company’s P/B ratio of 4.73 is significantly above the industry median of 1.82, indicating a premium valuation. However, its ROE of 8.31% is below the industry median of 10.31%, and its ROCE of 10.13% is also below the industry median of 12.96%. The sector’s market capitalisation ranges from Rs 6.45 crore to Rs 2,921.65 crore, with Medico Remedies Ltd. positioned towards the lower end of this spectrum. These metrics highlight the company’s valuation premium but also point to potential areas for operational improvement.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Dishman Carbogen Amcis Ltd. | DCAL | 2,921.65 | 29.31 | 0.43 | -2.89 | -0.26 |
| Kwality Pharmaceuticals Ltd. | KPL | 2,815.27 | 39.89 | 8.12 | 28.21 | 26.35 |
| Hikal Ltd. | HIKAL | 2,738.51 | 0 | 2.23 | 15.22 | 16.15 |
| Panacea Biotec Ltd. | PANACEABIO | 2,653.99 | 0 | 3.04 | 0 | 5.36 |
| Sai Parenteral's Ltd. | SAIPARENT | 2,476.69 | 169.37 | 3.13 | 13.9 | 12.97 |
Medico Remedies Ltd. (MEDICO) has a P/E ratio of 27.19x compared with the displayed peer median of 29.31x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 8.31% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at 10.13% versus the displayed peer median of 12.97%, providing a capital-efficiency comparison. Medico Remedies Ltd. (MEDICO) has a market capitalisation of Rs 356.67 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
In comparison to its peers, Medico Remedies Ltd. has a P/E ratio of 27.19, which is lower than Kwality Pharmaceuticals Ltd.’s 39.89 but higher than Venus Remedies Ltd.’s 17.65. Its P/B ratio of 4.73 is higher than Hikal Ltd.’s 2.23 and Panacea Biotec Ltd.’s 3.04. The company’s ROE of 8.31% is lower than Beta Drugs Ltd.’s 18.65% and Hester Biosciences Ltd.’s 16.17%. Similarly, its ROCE of 10.13% is below Kwality Pharmaceuticals Ltd.’s 26.35% and Beta Drugs Ltd.’s 22.17%. These comparisons indicate that while Medico Remedies Ltd. is valued at a premium, its profitability metrics lag behind some of its peers, suggesting areas for potential growth and efficiency improvements.
Why Investors Are Watching Medico Remedies Ltd.
Investors are closely monitoring Medico Remedies Ltd. due to its recent price rise and position within the Pharmaceuticals & Drugs industry.
- Price Action: Today’s 8.49% gain highlights significant market interest.
- Technical Position: The stock’s RSI indicates potential for further movement.
- Fundamental Context: Valuation metrics suggest a premium, with room for profitability improvement.
- Sector Positioning: Positioned in a dynamic industry with growth potential.
As the company navigates the competitive landscape, investors will be keen to see how it leverages its strengths and addresses its challenges.
About Medico Remedies Ltd.
Medico Remedies Ltd. is a player in the Pharmaceuticals & Drugs industry, operating within the Healthcare sector. The company focuses on the development, manufacturing, and marketing of pharmaceutical products. Its product portfolio includes a range of formulations catering to various therapeutic segments. With a market capitalisation of Rs 356.67 crore, Medico Remedies Ltd. is positioned as a micro-cap company, offering potential growth opportunities within its industry. The company’s strategic focus on innovation and quality positions it to capitalize on emerging trends in the healthcare sector.
Track Medico Remedies Ltd. Share Price on Univest
Use Medico Remedies Ltd. (MEDICO) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.
Investors can track Medico Remedies Ltd. Share Price on Univest for live updates, technical indicators, fundamental ratios, and market insights. Univest provides comprehensive data, including shareholding patterns, 52-week levels, and industry comparisons, enabling investors to make informed decisions based on real-time information.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is the current share price of Medico Remedies Ltd.?
Ans. The current share price of Medico Remedies Ltd. is Rs 46.63, reflecting an 8.49% increase from the previous close of Rs 42.98. The stock moved 8.49% during the session. The intraday range extended from Rs 42.81 to Rs 46.66.
How much did Medico Remedies Ltd. share price rise today?
Ans. Medico Remedies Ltd. share price rose by 8.49% today, increasing by Rs 3.65 to reach Rs 46.63. The stock moved 8.49% during the session. The intraday range extended from Rs 42.81 to Rs 46.66.
What is the market capitalisation of Medico Remedies Ltd.?
Ans. The market capitalisation of Medico Remedies Ltd. is Rs 356.67 crore, categorizing it as a micro-cap company. The company operates in the Healthcare sector. Its P/E ratio is 27.19x. ROE is 8.31% and ROCE is 10.13%.
What is the P/E ratio of Medico Remedies Ltd.?
Ans. The P/E ratio of Medico Remedies Ltd. is 27.19, slightly above the industry median of 26.37, indicating a relatively higher valuation. The company trades at a P/E ratio of 27.19x.
How does Medico Remedies Ltd.'s ROE compare to the industry?
Ans. Medico Remedies Ltd.'s ROE is 8.31%, which is below the industry median of 10.31%, suggesting room for improvement in profitability. ROE stands at 8.31%. ROCE stands at 10.13%. The relevant peer median ROE is 10.31%.
What industry does Medico Remedies Ltd. operate in?
Ans. Medico Remedies Ltd. operates in the Pharmaceuticals & Drugs industry, which is part of the broader Healthcare sector. The stock belongs to the Healthcare sector. Its industry classification is Pharmaceuticals & Drugs.
What is the P/B ratio of Medico Remedies Ltd.?
Ans. The P/B ratio of Medico Remedies Ltd. is 4.73, significantly above the industry median of 1.82, indicating a premium valuation. The company trades at a P/E ratio of 27.19x. Its P/B ratio is 4.73x.
How does Medico Remedies Ltd.'s ROCE compare to peers?
Ans. Medico Remedies Ltd.'s ROCE is 10.13%, which is below the industry median of 12.96%, indicating potential for operational improvement. ROE stands at 8.31%. ROCE stands at 10.13%. The relevant peer median ROE is 10.31%.
